Gritgen Therapeutics-preview

Gritgen

Gritgen Therapeutics

Private

SuzhouHealthcare & Life Scienceshttps://www.gritgen.com/

Last Round

Series A

Mar 2, 2022

Total Funding Raised

$59.33M

Company Overview

Gritgen Therapeutics is a biotechnology company that develops gene therapies for rare and common diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

AAV gene therapygene therapycell and gene therapyadeno-associated virusAAVHemophilia A treatmentviral vectorclinical stage biotechGMP manufacturingrare disease therapyAAV capsid platformbiomanufacturingHereditary AngioedemaHAEophthalmology gene therapypromoter enhancer technology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Gritgen Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Gritgen Therapeutics Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Mar 2, 2022
Pre Seed	Dec 1, 2020

View all Funding Rounds

Gritgen Therapeutics Investors

Notable investors and investment history

Investor	Rounds
Qingsong Fund	Series A
HongShan	Series A
Sunshine Insurance Group	Series A
China Everbright Limited	Series A, Pre Seed
Gaorong Capital	Pre Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Mar 2, 2022
$47M round led by HongShan.
Dec 1, 2020
$12M round led by China Everbright Limited

View all signals

Gritgen Therapeutics Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Gritgen Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Gritgen Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSuzhou

Employee Range3

Year Founded2019

Last FundingMar 2, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.